PMV Pharmaceuticals, Inc. ( PMVP) - Key Metrics
PMVP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.34 | -$0.27 | -$0.27 |
| 2026Q1 | $0 | -$0.34 | -$0.37 | -$0.37 |
| 2025Q4 | $0 | -$0.34 | -$0.32 | -$0.32 |
| 2025Q3 | $0 | -$0.40 | -$0.37 | -$0.37 |
| 2025Q2 | $0 | -$0.41 | -$0.35 | -$0.35 |
PMVP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.99 |
| 2026Q1 | 0% | -0.91 |
| 2025Q4 | 0% | -0.92 |
| 2025Q3 | 0% | -0.87 |
| 2025Q2 | 0% | -0.65 |
PMVP
Price: $1.21
52 week price:
Earnings Per Share: -1.42 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 230900
Market Capitalization: 95.5 million